DN-1289

1 Cited Publications
Revisión del cliente

Based on 1 publication(s) in Google Scholar

DN-1289 is an orally active and selective inhibitor of dual leucine zipper kinase (DLK; IC50=17 nM) and leucine zipper-bearing kinase (LZK; IC50=40 nM). DN-1289 results significant attenuation of optic nerve crush (ONC)-induced p-c-Jun in mice model. DN-1289 has excellent in vivo plasma half-life and blood-brain barrier permeability.

Para uso exclusivo en investigación. No vendemos a pacientes.

  • Pureza: 99.63%
  • No. CAS: 3026597-15-6
  • Fòrmula: C18H19F4N7O2
  • Peso molecular:441.38
  • Almacenamiento:
    Powder   -20°C, 3 years , 4°C, 2 years ; In solvent   -80°C, 6 months , -20°C, 1 month
  • Actividad biológica
  • Chemical Information
  • Solvente y solubilidad
  • Pureza y Documentación
  • Referencias
  • Help & FAQs

Publications Citing Use of MedChemExpress (MCE) DN-1289

More

Ver todos los productos específicos de isoformas JNK

More
100 mg

Obtener un presupuesto En stock

Please select quantity
Amount: USD 0.00